TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Device Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Voice handicap index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to immunosuppressive medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse psychological outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse physical outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Adaptive behaviour on the Vineland Adaptive Behaviour Scales
Endpoint domain: Life impact
Endpoint subdomain: Functional functioning
Primary endpoint: Executive function behaviours on the Behaviour Rating Inventory of Executive Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: School-related task performance on the School Function Assessment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Social skills on the Walker Mc-Connell scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of participants who have achieved radiologic fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Neck Disability Index (NDI) with a response greater than or equal to 15 from baseline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with neurological success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Agreement between MRI and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AI (Aortic-to-radial pressure gradient)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HCC recurrence at 5-year follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Clinical Dementia Rating-Sum of Boxes (CDR-SB) change score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of treatment (completion of one session)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance (completion of at least 3 sessions)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total weekly alcohol intake (measured by Timeline follow back)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients requiring Astigmatism Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Internal Body Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regrowth Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of E7449
Endpoint domain: Adverse events/effects
Primary endpoint: Composite Endpoint of Fatal Stroke, Recurrent Ischemic Stroke, or TIA
Endpoint domain: Mortality/survival
Primary endpoint: Uptake of 18F-FAZA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Patients Reaching Treatment Success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite Cardiovascular Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Adverse Event Category Rates
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of infants crying
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants With No Evidence of Cervical HSIL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: No Evidence of HPV-16 and/or HPV-18 in Cervical Samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Occurrence of recurrent disease
Endpoint domain: Mortality/survival
Primary endpoint: Range of Motion: knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal visceral adipose tissue loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electroretinogram Pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vision field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Optical coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transdermal Adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Treatment-Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Treatment-Emergent Serious Adverse Events (TESAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Treatment Success Patients at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orbital implant and ocular prosthesis motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical conditions assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Wear Rate Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CABG Patency index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of vein harvesting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical success as evaluated by patient improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants Achieving ASAS40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation-related adverse acute respiratory event
Endpoint domain: Adverse events/effects
Primary endpoint: Apnea-hypnea-Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen-desaturation-Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Cerebral Artery Vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Substance loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor Gene Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of Herceptin in advanced breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Migraine Headache Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent to complete dialing up insulin pens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Leukocyte Level at Postpartum Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of Number of Patients with Fever
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Postpartum Endometritis
Endpoint domain: Adverse events/effects
Primary endpoint: Blood glucose regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in number of medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Parts of the intervention completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in the Electronic Medication Profile (FMK)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Western Aphasia Battery Revised Language Quotient (LQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Boston University Activity Measure for Post-Acute Care (AM-PAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Community Participation Indicators (CPI)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Stroke Impact Scale (SIS) Participation domain
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Responsiveness ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early neurological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Small Intestinal Permeability Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sensitivity of fungal biomarker assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of fungal biomarker assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Threshold for positive result of fungal biomarker assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of PVR (∆PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual heat pain tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self Reported Medication Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Low-Density Lipoprotein (LDL) Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in brain background rhythms (mu-alpha and beta activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hypoglycemic Episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Regional brain function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Coronary artery calcium scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Dose-limiting Toxicity (DLT) Incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients Who Achieve a Partial Response or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Visual Analogous Scales for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first bowel evacuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Volume of the caudate nuclei
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Size of the area of secondary hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery score (QoR40)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in knowledge related to colorectal cancer risk, prevention, and screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in colorectal cancer screening and other risk behavior intentions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in colorectal cancer screening behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: CRi (complete remission without count recovery)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative neurological improvement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of fluid administration changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement performance of an intravascular oxygen sensor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth of endometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestation at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Completion of non-contrast 3D MRA aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Self-report drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance Binocular LogMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Near Binocular LogMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermediate Binocular LogMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes Per Week of Moderate-to-vigorous Intensity Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical performance of the AmniSure® ROM test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Wounds Closed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parenting Stress Index (PSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to step up therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and Intensity of Pain on Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding after kidney biopsy
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Negative Predictive Value of Prothrombin Fragment F1+2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Modified Sphygmomanometer test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in the papillary bleeding index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the percentage of study sites positive for bleeding on probing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of Eovist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of Eovist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Virologic Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infant HIV-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Pancreatic fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in social reciprocity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Pittsburgh Insomnia Rating Scale (PIRS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total fentanyl consumption during 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Mortality, Ongoing Need for Hospitalization, or Mechanical Ventilation at Day 15
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Concentration (Cmax) of Tabalumab After Loading Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve From Time 0 to 14 Days (AUC 0-14) of Tabalumab After Loading Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who convert to multiple sclerosis
Endpoint domain: Mortality/survival
Primary endpoint: Mean nighttime blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quebec Back Pain Disability Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 10-Meter Walk Test at Self-Selected Speed (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of adverse events after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Putative Tumor Initiating Cell Populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Tumor Cell Surface CD44 Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cervical joint proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of adenosine perfusion scintigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shoulder function change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in area under curve dose-response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Clinically Relevant Non Major Bleeding Events
Endpoint domain: Adverse events/effects
Primary endpoint: Suicide Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) in the Treatment Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Newly Emergent Adverse Events (NEAEs) in the Safety Follow-up Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes From Baseline in Clinical Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported experience measure (PREM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes of global cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cuff-pressure mechanical sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity to mechanical point pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in hemoglobin (Hb) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adherence Rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Brain oxygenation (NIRS value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood lactate concentration accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of intraoperative IV fentanyl administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplant success or failure
Endpoint domain: Mortality/survival
Primary endpoint: Plasma Estradiol (E2) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Tricuspid Annular Plane Systolic Excursion (TAPSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of Swine A/H1N1 influenza vaccines
Endpoint domain: Adverse events/effects
Primary endpoint: Binge Eating Episodes - Loss of Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binge Eating Episodes - Overeating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and toxicity profile of CldC+ H4U
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of Tear Cytokine Levels Before Punctal Plug Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Tear Cytokine Levels Following Punctal Plug Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom improval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periprosthetic joint infections
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative time requiring mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall duration of neurocritical care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ipsilateral axillary recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in Mean Number of Stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disease activity score (DAS) 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasmatic concentration of polyphenols and their metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in concentration of polyphenols in urine and their metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in flow in LIMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Depression severity measured by HRSD-17
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients Who Fail to Receive Vaccinations
Endpoint domain: Adverse events/effects
Primary endpoint: Number of days between hemodynamic stability and ICU discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N.Meningitidis Human Serum Bactericidal Activity (hSBA) Titers≥ 1:4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in the Jackson scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in WURSS-21 Quality of Life sub score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Patients Willing to be Randomized
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average width of OC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average height of OC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average area of OC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Plasma Paracetamol Concentration of 0.25 μg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes